Is PDL BioPharma (pdli) stock a good buy?
The company was formerly known as Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006. PDL BioPharma, Inc. was founded in 1986 and is headquartered in Incline Village, Nevada. Is PDLI A Good Stock To Buy Now? There is not enough analysis data for PDL BioPharma. PDL BioPharma has received 221 “outperform” votes.
Does PDL BioPharma stock outperform or underperform the S&P 500?
Vote “Outperform” if you believe PDLI will outperform the S&P 500 over the long term. Vote “Underperform” if you believe PDLI will underperform the S&P 500 over the long term. You may vote once every thirty days. PDL BioPharma does not currently pay a dividend. PDL BioPharma does not have a long track record of dividend growth.
What is PDL BioPharma's PE (PDL) ratio compared to its peers?
Only 13.49% of the stock of PDL BioPharma is held by institutions. The P/E ratio of PDL BioPharma is -2.19, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
What is the history of PDL BioPharma?
The company was formerly known as Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006. PDL BioPharma, Inc. was founded in 1986 and is headquartered in Incline Village, Nevada.
How were PDL BioPharma's earnings last quarter?
PDL BioPharma, Inc. (NASDAQ:PDLI) posted its quarterly earnings results on Thursday, August, 6th. The biotechnology company reported ($0.43) EPS fo...
Who are PDL BioPharma's key executives?
PDL BioPharma's management team includes the following people: Mr. Dominique P. Monnet , CEO, Pres & Director (Age 59, Pay $1.2M) Mr. Edward A....
Who are some of PDL BioPharma's key competitors?
Some companies that are related to PDL BioPharma include Amgen (AMGN) , Gilead Sciences (GILD) , Vertex Pharmaceuticals (VRTX) , Regeneron Phar...
What other stocks do shareholders of PDL BioPharma own?
Based on aggregate information from My MarketBeat watchlists, some companies that other PDL BioPharma investors own include AT&T (T) , OPKO Healt...
What is PDL BioPharma's stock symbol?
PDL BioPharma trades on the NASDAQ under the ticker symbol "PDLI."
What is PDL BioPharma's stock price today?
One share of PDLI stock can currently be purchased for approximately $2.47.
How much money does PDL BioPharma make?
PDL BioPharma (NASDAQ:PDLI) has a market capitalization of $282.86 million and generates $54.76 million in revenue each year.
How many employees does PDL BioPharma have?
PDL BioPharma employs 109 workers across the globe.
What is PDL BioPharma's official website?
The official website for PDL BioPharma is www.pdl.com .
How were PDL BioPharma's earnings last quarter?
PDL BioPharma, Inc. (NASDAQ:PDLI) posted its quarterly earnings data on Thursday, August, 6th. The biotechnology company reported ($0.43) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of $0.10 by $0.53. The biotechnology company earned $5.21 million during the quarter. View PDL BioPharma's earnings history.
Who are some of PDL BioPharma's key competitors?
Some companies that are related to PDL BioPharma include Amgen (AMGN), Gilead Sciences (GILD), Regeneron Pharmaceuticals (REGN), Vertex Pharmaceuticals (VRTX), Biogen (BIIB), Seagen (SGEN), Alnylam Pharmaceuticals (ALNY), BioMarin Pharmaceutical (BMRN), Incyte (INCY), Exact Sciences (EXAS), Repligen (RGEN), United Therapeutics (UTHR), Neurocrine Biosciences (NBIX), Novavax (NVAX) and Exelixis (EXEL). View all of PDLI's competitors..
What other stocks do shareholders of PDL BioPharma own?
Based on aggregate information from My MarketBeat watchlists, some companies that other PDL BioPharma investors own include AT&T (T), OPKO Health (OPK), (CGC), Advanced Micro Devices (AMD), Novavax (NVAX), General Electric (GE), Teva Pharmaceutical Industries (TEVA), Bank of America (BAC), Bausch Health Companies (BHC) and Cara Therapeutics (CARA).
What is PDL BioPharma's stock price today?
One share of PDLI stock can currently be purchased for approximately $2.47.
How much money does PDL BioPharma make?
PDL BioPharma has a market capitalization of $282.86 million and generates $54.76 million in revenue each year.
Where are PDL BioPharma's headquarters?
PDL BioPharma is headquartered at 932 SOUTHWOOD BLVD, INCLINE VILLAGE NV, 89451.
Barchart Technical Opinion
The Barchart Technical Opinion rating is a 64% Sell with a Average short term outlook on maintaining the current direction.
Business Summary
Protein Design Labs Inc. is a biopharmaceutical company focused on the research, development and commercialization of novel therapies for inflammation and autoimmune diseases, acute cardiac conditions and cancer. PDL markets several biopharmaceutical products in the United States through its hospital...
What time is after hours trading?
About After Hours Quotes. Nasdaq provides market information on after hours trading daily from 4:15 p.m. ET to 3:30 p.m. ET on the following day.
What time do you trade after hours?
After-Hours Trades. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these sessions may offer less liquidity and inferior prices.
What time is after hours trading?
About After Hours Quotes. Nasdaq provides market information on after hours trading daily from 4:15 p.m. ET to 3:30 p.m. ET on the following day.
What time do you trade after hours?
After-Hours Trades. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these sessions may offer less liquidity and inferior prices.
